Pacira BioSciences' Change in Cash fell 13952.85% to -$152.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$98.4 million, marking a year-over-year decrease of 166.99%. This contributed to the annual value of $123.5 million for FY2024, which is 151.18% up from last year.
As of Q3 2025, Pacira BioSciences' Change in Cash stood at -$152.9 million, which was down 1,006.10% from $16.9 million recorded in Q2 2025.
In the past 5 years, Pacira BioSciences' Change in Cash registered a high of $451.5 million during Q4 2021, and its lowest value of -$358.8 million during Q1 2022.
Its 3-year average for Change in Cash is $4.0 million, with a median of $16.9 million in 2025.
Its Change in Cash has fluctuated over the past 5 years, first skyrocketed by 1,885.67% in 2021, then tumbled by 13,952.85% in 2025.
Pacira BioSciences' Change in Cash (Quarterly) stood at $451.5 million in 2021, then crashed by 101.17% to -$5.3 million in 2022, then skyrocketed by 1,125.15% to $54.2 million in 2023, then slumped by 43.13% to $30.8 million in 2024, then crashed by 13,952.85% to -$152.9 million in 2025.
Its last three reported values are -$152.9 million in Q3 2025, $16.9 million for Q2 2025, and $6.8 million during Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value